1.70
price down icon2.86%   -0.05
after-market Dopo l'orario di chiusura: 1.78 0.08 +4.71%
loading
Precedente Chiudi:
$1.75
Aprire:
$1.71
Volume 24 ore:
28,496
Relative Volume:
0.25
Capitalizzazione di mercato:
$66.15M
Reddito:
$134.00K
Utile/perdita netta:
$-9.93M
Rapporto P/E:
-5.00
EPS:
-0.34
Flusso di cassa netto:
$-6.72M
1 W Prestazione:
-12.82%
1M Prestazione:
-8.11%
6M Prestazione:
-10.53%
1 anno Prestazione:
+1.80%
Intervallo 1D:
Value
$1.65
$1.73
Intervallo di 1 settimana:
Value
$1.65
$1.9587
Portata 52W:
Value
$1.41
$3.35

Entera Bio Ltd Stock (ENTX) Company Profile

Name
Nome
Entera Bio Ltd
Name
Telefono
972-2-532-7151
Name
Indirizzo
KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
ENTX's Discussions on Twitter

Confronta ENTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ENTX
Entera Bio Ltd
1.70 66.15M 134.00K -9.93M -6.72M -0.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Entera Bio Ltd Stock (ENTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-03-22 Iniziato Aegis Capital Buy

Entera Bio Ltd Borsa (ENTX) Ultime notizie

pulisher
Mar 29, 2025

Entera Bio Reports Transformative Year in 2024 - TipRanks

Mar 29, 2025
pulisher
Mar 28, 2025

Entera Bio Ltd. (ENTX) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

Entera Bio Announces 2024 Financial Results and Updates - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Entera Bio's Breakthrough: Oral Peptide Programs Show Promise as 2024 Results Reveal $21M War Chest - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Mar 28, 2025
pulisher
Mar 21, 2025

Entera Bio Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 19, 2025

Entera Bio’s (ENTX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Opko Health, Entera Bio sign agreement for oral GLP-1/glucagon dual agonist peptide - BioWorld MedTech

Mar 18, 2025
pulisher
Mar 18, 2025

OPKO and Entera team up on oral obesity candidate - The Pharma Letter

Mar 18, 2025
pulisher
Mar 18, 2025

OPKO and Entera Bio partner on oral obesity treatment By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

OPKO And Entera Bio Team Up For Game-Changing Obesity Pill - Finimize

Mar 18, 2025
pulisher
Mar 17, 2025

OPKO and Entera partner to develop obesity pill -March 17, 2025 at 08:54 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Entera Bio Collaborates with OPKO for Oral GLP-1/Glucagon - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

OPKO, Entera to Co-Develop Oral GLP-1/Glucagon Therapy for Obesity -March 17, 2025 at 08:38 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

OPKO and Entera Bio partner on oral obesity treatment - Investing.com India

Mar 17, 2025
pulisher
Mar 17, 2025

OPKO Health and Entera Bio Enter into Collaboration - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera Join Forces to Challenge Injectable Market - StockTitan

Mar 17, 2025
pulisher
Mar 17, 2025

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera Bio Join Forces for Game-Changing Pill - Stock Titan

Mar 17, 2025
pulisher
Mar 07, 2025

Entera Bio (ENTX) Expected to Announce Quarterly Earnings on Friday - Defense World

Mar 07, 2025
pulisher
Feb 28, 2025

Entera Bio Ltd. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 24, 2025

Entera Bio to Participate in Upcoming Events - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Can Entera Bio's Upcoming Scientific Data Reshape Oral Peptide Therapy? Major Conference Schedule Revealed - Stock Titan

Feb 24, 2025
pulisher
Feb 19, 2025

EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskel - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Could This Oral Osteoporosis Treatment Replace Daily Injections? Phase 2 Data Reveals Promising Results - StockTitan

Feb 19, 2025
pulisher
Feb 17, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 31.6% in January - MarketBeat

Feb 17, 2025
pulisher
Feb 07, 2025

US Penny Stocks: 3 Picks With Market Caps Over $60M - Yahoo Finance

Feb 07, 2025
pulisher
Feb 06, 2025

Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Feb 06, 2025
pulisher
Feb 04, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short Interest - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

145,843 Shares in Entera Bio Ltd. (NASDAQ:ENTX) Acquired by Perigon Wealth Management LLC - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Down 23.1% in January - MarketBeat

Feb 03, 2025
pulisher
Jan 27, 2025

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Jan 27, 2025
pulisher
Jan 27, 2025

Entera Bio CEO to Present Business Updates at Oppenheimer Healthcare Conference - StockTitan

Jan 27, 2025
pulisher
Jan 18, 2025

Entera Bio Ltd. (NASDAQ:ENTX) Sees Significant Decrease in Short Interest - Defense World

Jan 18, 2025
pulisher
Jan 10, 2025

Entera Bio files Exhibit 5.1 with SEC By Investing.com - Investing.com South Africa

Jan 10, 2025
pulisher
Jan 10, 2025

Entera Bio files Exhibit 5.1 with SEC - Investing.com

Jan 10, 2025
pulisher
Jan 07, 2025

Entera Bio (NASDAQ:ENTX) Stock Price Up 1.1% – Still a Buy? - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Entera Bio (NASDAQ:ENTX) Shares Up 1.1%Time to Buy? - MarketBeat

Jan 07, 2025
pulisher
Dec 24, 2024

Hypoparathyroidism Market Overview, Trends, Insights, - openPR

Dec 24, 2024
pulisher
Dec 07, 2024

We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate - Simply Wall St

Dec 07, 2024
pulisher
Dec 01, 2024

Short Interest in Entera Bio Ltd. (NASDAQ:ENTX) Rises By 19.0% - MarketBeat

Dec 01, 2024
pulisher
Nov 20, 2024

Knoll Capital Management, LLC's Strategic Acquisition in Entera Bio Ltd - GuruFocus.com

Nov 20, 2024
pulisher
Nov 17, 2024

Entera Bio Ltd. (NASDAQ:ENTX) Short Interest Update - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

FY2024 EPS Estimate for Entera Bio Decreased by Analyst - MarketBeat

Nov 14, 2024

Entera Bio Ltd Azioni (ENTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):